COVID-19 Boosters in Autoimmune Rheumatic and Musculoskeletal Patients
Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »